Key Takeaways Incyte (INCY) has put up a good performance in the past three months. Shares of the company have gained 9.2% against the industry's decline of 1.3%. The stock has also outperformed the sector in the said timeframe. INCY Outperforms Industry & Sector The outperformance can be attributed to positive pipeline and regulatory updates. Lead drug Jakafi (ruxolitinib) also maintains momentum. Let us take a look at what's happening with Incyte. Pipeline/Regulatory Updates Boost INCY Stock Last month, t ...

W&T Offshore (WTI) Q1 2025 Earnings Call May 07, 2025 12:00 PM ET Company Participants Al Petrie - Investor Relations CoordinatorTracy Krohn - Founder, Chairman, CEO & PresidentDerrick Whitfield - Managing DirectorJeffrey Robertson - Managing DirectorWilliam Williford - EVP and COO Conference Call Participants John White - MD & Senior Research Analyst Operator Ladies and gentlemen, thank you for standing by. Welcome to the W and T Offshore First Quarter twenty twenty five Conference Call. During today's cal ...